United States · FDA National Drug Code directory
OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 33342-173_79da177b-5eeb-4d95-b949-251b7e8c948b
- Product NDC
- 33342-173
- Form
- TABLET, FILM COATED
- Composition / generic term
- OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE
- Labeler
- Macleods Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230602
- Source listing expiry
- 20261231
Source-listed ingredients
- OLMESARTAN MEDOXOMIL — 20 mg/1
- HYDROCHLOROTHIAZIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (33342-173-07) · 33342-173-07
- 90 TABLET, FILM COATED in 1 BOTTLE (33342-173-10) · 33342-173-10
- 10 BLISTER PACK in 1 CARTON (33342-173-12) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 33342-173-12
- 1000 TABLET, FILM COATED in 1 BOTTLE (33342-173-44) · 33342-173-44
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →